Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 9 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]        
Net revenues $ 10,321,754 $ 9,727,060 $ 30,842,874 $ 23,074,984
Cost of sales 3,802,636 3,155,902 9,618,163 7,250,895
Gross profit 6,519,118 6,571,158 21,224,711 15,824,089
Operating expenses:        
Research and development 4,436,496 4,866,114 13,666,730 10,138,524
Selling, general and administrative 3,475,474 3,547,046 11,034,904 10,663,884
Total operating expenses 7,911,970 8,413,160 24,701,634 20,802,408
Operating loss (1,392,852) (1,842,002) (3,476,923) (4,978,319)
Non-operating (expenses) income:        
Interest expense (1,169,692) (1,091,276) (3,476,079) (3,627,971)
Change in fair value of derivative liabilities (169,000) 157,000 (94,000) (246,000)
Other (expense) income, net (53,334) 1,744 (63,369) 12,588
Total non-operating expenses (1,392,026) (932,532) (3,633,448) (3,861,383)
Loss before income taxes (2,784,878) (2,774,534) (7,110,371) (8,839,702)
Income tax expense (benefit) 240,502 (458) 30,619 117,207
Net loss $ (3,025,380) $ (2,774,076) $ (7,140,990) $ (8,956,909)
Net loss per basic and diluted common share outstanding $ (0.05) $ (0.04) $ (0.11) $ (0.14)
Basic and diluted weighted average common shares outstanding 66,728,782 62,917,362 65,709,139 62,745,355